• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Dig Dis . Liver damage at admission is an independent prognostic factor for COVID-19

tetano

Editor, Senior Moderator
J Dig Dis


. 2020 Jul 26.
doi: 10.1111/1751-2980.12925. Online ahead of print.
Liver damage at admission is an independent prognostic factor for COVID-19


Liu Ying Chen[SUP] 1 [/SUP], Hui Kuan Chu[SUP] 1 [/SUP], Tao Bai[SUP] 1 [/SUP], Sheng Jin Tu[SUP] 2 [/SUP], Yuan Wei[SUP] 2 [/SUP], Zhong Lin Li[SUP] 1 [/SUP], Li Ling Hu[SUP] 1 [/SUP], Rui Zhu[SUP] 3 [/SUP], Lei Zhang[SUP] 1 [/SUP], Chao Qun Han[SUP] 1 [/SUP], Li Xiao[SUP] 1 [/SUP], Qi He[SUP] 1 [/SUP], Jun Song[SUP] 1 [/SUP], Wei Hua Liu[SUP] 2 [/SUP], Qing Jing Zhu[SUP] 4 [/SUP], Hua Chen[SUP] 2 [/SUP], Ling Yang[SUP] 1 [/SUP], Xiao Hua Hou[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: Abnormal liver function has been noticed as common extra pulmonary organ damage of the coronavirus disease 2019 (COVID-19). Severe patients had a higher probability and progression of liver injury compared with non-severe patients. We aimed to investigate the prognostic value of liver injury in COVID-19 patients.
Methods: We retrospectively included 502 patients with laboratory-confirmed SARS CoV-2 infection. Clinical features and survival of patients with and without liver injury were compared. Cox proportional hazard ratio models were used to find the variables that have an effect on survival.
Results: Among enrolled 502 patients, 301 patients had abnormal liver function with increased neutrophil count, C-reactive protein (CRP), creatinine, troponin (TnI), D-dimer, lactose dehydrogenase (LDH) and creatine kinase (CK). Compared to patients with normal liver functions, those with abnormal liver functions had higher mortality rate (28.9% vs 9.0%, P<0.001), higher ratio of male patients (65.1% vs 40.8%, P<0.001) and higher chance of SIRS development (53.5% vs 41.3%, P=0.007). Among patients with abnormal liver functions, liver damage grade 2 patients (both ALT/AST and ALP/GGT abnormal) had higher ratio of male patients, neutrophil count, PCT, D-dimer and mortality rate. Multivariate Cox regression analyses suggested that grade of liver damage (HR:1.377, 95%CI:1.000-1.896, P=0.049) was an independent predictor of death.
Conclusions: COVID-19 patients with abnormal liver functions have a higher mortality. Liver damage is an independent prognostic factor of COVID-19. This article is protected by copyright. All rights reserved.
 
Back
Top Bottom